![Peter Silverman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Silverman
Direktor/Vorstandsmitglied bei
LEONABIO, INC.
Vermögen: - $ am 31.07.2026
Profil
Peter B. Silverman is Director at Kinaset Therapeutics, Inc. since 2026.
Independent Director at LeonaBio, Inc. and Yarrow Bioscience, Inc. since 2026.
Partner at Forge Life Science Partners, LLC.
Formerly Partner at Kirkland & Ellis LLP from 2012 to 2017.
Associate at Kaye Scholer LLP from 2007 to 2012.
Executive Vice President & General Counsel at Merus NV from 2018 to 2023.
Educated at Rochester Christian University (undergraduate) and Fordham University School of Law (graduate).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LEONABIO, INC. -.--% | 23.06.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Peter Silverman
| Unternehmen | Position | Beginn |
|---|---|---|
| LEONABIO, INC. | Direktor/Vorstandsmitglied | 05.05.2026 |
Forge Life Science Partners
 Forge Life Science Partners Investment ManagersFinance Forge Life Science Partners invests in companies located in the United States. The firm focuses on companies operating in the field of the healthcare sector. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Direktor/Vorstandsmitglied | 01.01.2026 |
Ehemalige bekannte Positionen von Peter Silverman
| Unternehmen | Position | Ende |
|---|---|---|
| MERUS N.V. | Geschäftsführer | 12.12.2025 |
Kirkland & Ellis LLP
 Kirkland & Ellis LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Corporate Officer/Principal | 01.02.2017 |
Kaye Scholer LLP
 Kaye Scholer LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.05.2012 |
Ausbildung von Peter Silverman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Kirkland & Ellis LLP
Kirkland & Ellis LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Kaye Scholer LLP
Kaye Scholer LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Fordham University School of Law
 Fordham University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics for respiratory diseases | Health Technology |
Forge Life Science Partners
Forge Life Science Partners Investment ManagersFinance Forge Life Science Partners invests in companies located in the United States. The firm focuses on companies operating in the field of the healthcare sector. It provides financing for early stage capital requirements. | Finance |
